| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | Jan 31, 2025 | TriSalus Life Sciences, Inc. | CEO | Buy | 82.5 | +10,040 | 2.31% | ✗ | $51.8K |
| Jan 27, 2025 | Jan 29, 2025 | TriSalus Life Sciences, Inc. | CEO | Buy | 95.0 | +49,542 | 12.88% | ✗ | $50.3K |
| Sep 12, 2024 | Sep 13, 2024 | TriSalus Life Sciences, Inc. | CEO | Buy | 87.5 | +14,815 | 4.01% | ✗ | $75.4K |
| Sep 10, 2024 | Sep 12, 2024 | TriSalus Life Sciences, Inc. | CEO | Buy | 78.8 | +5,000 | 1.37% | ✗ | $24.9K |
| Jun 22, 2020 | Jun 24, 2020 | Coherus Oncology, Inc. | Director | Sell | 20.0 | -54,997 | -100.00% | ✗ | $966.8K |